The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
Two weeks into the job, it’s clear that newly elected State Treasurer Brad Briner won’t shy away from taking action, even if ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
GOBankingRates on MSN3h
Mark Cuban Wants To Reshape Healthcare — 5 Ways His Approach Could Save Americans MoneyFor many living in America, healthcare is both complicated and expensive. But Mark Cuban thinks there's another way. The ...
So now I don't have my prescription, and the actual physical CVS won't fill my prescription because it's too soon to fill it. I feel like someone has tampered with my medication. And I don't want ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...
Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback